Terms: = Liver cancer AND FANCE, 2178, ENSG00000112039, FAE AND Prognosis
5 results:
1. Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy.
Fulop DJ; Zylberberg HM; Wu YL; Aronson A; Labiner AJ; Wisnivesky J; Cohen DJ; Sigel KM; Lucas AL
JAMA Netw Open; 2023 Mar; 6(3):e234254. PubMed ID: 36951863
[TBL] [Abstract] [Full Text] [Related]
2. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor prognosis in Hepatocellular Carcinoma.
Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
[TBL] [Abstract] [Full Text] [Related]
3. liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.
Fukami Y; Kaneoka Y; Maeda A; Kumada T; Tanaka J; Akita T; Kubo S; Izumi N; Kadoya M; Sakamoto M; Nakashima O; Matsuyama Y; Kokudo T; Hasegawa K; Yamashita T; Kashiwabara K; Takayama T; Kokudo N; Kudo M;
Ann Surg; 2020 Jul; 272(1):145-154. PubMed ID: 30672806
[TBL] [Abstract] [Full Text] [Related]
4. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract] [Full Text] [Related]
5. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.
Pracht M; Le Roux G; Sulpice L; Mesbah H; Manfredi S; Audrain O; Boudjema K; Raoul JL; Boucher E
Chemotherapy; 2012; 58(2):134-41. PubMed ID: 22572213
[TBL] [Abstract] [Full Text] [Related]
